AlphaGrep UK’s Elevance Health ELV Stock Holding History

AlphaGrep UK’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$720K	Sell	1,861 -113	-6%	-$41.9K	0.21%	108
2026 Q1	$578K	Buy	1,974 +1,085	+122%	+$357K	0.17%	178
2025 Q4	$312K	Buy	+889	New	+$300K	0.1%	408

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

AlphaGrep UK's ELV Position: Q2 2026 in Review

AlphaGrep UK reduced its Elevance Health (ELV) stake by 5.7% in Q2 2026, selling an estimated $41.9K and leaving 1,861 shares worth $720K. The position accounts for 0.21% of the portfolio, ranked #108.

AlphaGrep UK first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

AlphaGrep UK held 1,861 shares of Elevance Health worth $720K as of Q2 2026.
AlphaGrep UK sold 113 Elevance Health shares in Q2 2026, an estimated $41.9K.
Elevance Health made up 0.21% of AlphaGrep UK's portfolio in Q2 2026, its #108 holding.
AlphaGrep UK first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.